Actualizado 18/06/2008 18:24
- Comunicado -

Gerresheimer Discontinues Marginal Operations

DÜSSELDORF, Germany, June 18 /PRNewswire/ --

-- Sale of Consumer Healthcare Business

-- Concentration on Core Business of Pharmaceutics and Life Science

Gerresheimer AG, the leading manufacturer of glass and plastic products for the pharma & life science industry, is selling its consumer healthcare business. As previously announced, the Düsseldorf company is thereby discontinuing operations which are not part of the core business of pharmaceutics and life science.

"The consumer healthcare business did not fit in with our strategy of focussing on the fields of pharmaceutics and life science. In addition, because of the lack of synergies with the core business, our return requirements for the consumer healthcare business were not fulfilled," says Gerresheimer CEO Dr. Axel Herberg.

The consumer healthcare business, which comprises the production of toothbrushes and other interdental articles and most recently achieved annual sales of EUR24m, was part of the Wilden Group, which was acquired in January 2007. The purchaser is the Krallmann Group. Through the acquisition, Krallmann intends to expand its own plastic processing division and to continue the business under the traditional "Interbros" trademark. The transaction takes place with effect on 1 June 2008. The contractual parties have agreed to keep further details confidential.

Early this year, Gerresheimer already discontinued the marginal business of aluminium packaging with sales of EUR3.3m.

About Gerresheimer

Gerresheimer employs more than 10,800 people in 41 locations in Europe, America and Asia. In the financial year 2007, worldwide sales totalled EUR957.7m. The product portfolio ranges from pharmaceutical vials made of glass and plastic through to complex drug-delivery systems for the pharma & life science industry. These include sterile syringes, inhalers and other system-based approaches for safe dosage and application of medications. The Group enjoys a leading position in markets which are characterised by high technical and regulatory barriers.

    
    Contact Press                       Contact Investor Relations
    Burkhard Lingenberg                 Anke Linnartz
    Director Corporate PR & Marketing   Director Corporate Investor Relations
    Telephone +49-211-6181-250          Telephone +49-211-6181-314
    Telefax +49-211-6181-241            Telefax +49-211-6181-121
    E-mail                              E-mail
    b.lingenberg@gerresheimer.com       a.linnartz@gerresheimer.com

Contact Press, Burkhard Lingenberg, Director Corporate PR & Marketing, Telephone +49-211-6181-250, Telefax +49-211-6181-241, E-mail b.lingenberg@gerresheimer.com; Contact Investor Relations, Anke Linnartz, Director Corporate Investor Relations, Telephone +49-211-6181-314, Telefax +49-211-6181-121, E-mail a.linnartz@gerresheimer.com

Comunicados

Si quieres mejorar el posicionamiento online de tu marca, ahora puedes publicar tus notas de prensa o comunicados de empresa en la sección de Comunicados de europa press

Si necesitas asesoramiento en comunicación, redacción de tus notas de prensa o ampliar la difusión de tu comunicado más allá de la página web de europa press, ponte en contacto con nosotros en comunicacion@europapress.es o en el teléfono 913592600